J. Alffenaar

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

T. Shim, Alimuddin Zumla, A. Spanevello, 2012, European Respiratory Journal.

Clinical standards for the dosing and management of TB drugs

D. van Soolingen, P. Denti, K. Dheda, 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex.

S. Shin, V. Sintchenko, C. Köser, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical standards for drug-susceptible pulmonary TB

K. Dooley, B. D. de Jong, K. Dheda, 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Determination of Flucytosine in Human Serum using Liquid Chromatography-Tandem Mass Spectrometry

K. V. Hateren, D. Touw, J. Alffenaar, 2018, Journal of Applied Bioanalysis.

Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in Children

D. Deshpande, S. Srivastava, T. Gumbo, 2020, The Pediatric infectious disease journal.

The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment.

A. Märtson, J. Alffenaar, H. Y. Kim, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Successful treatment of patients severely ill with COVID-19.

Y. Hu, J. Liu, J. Zhu, 2020, The International Journal of Tuberculosis and Lung Disease.

Clinical standards for the management of adverse effects during treatment for TB

Shashank Srivastava, K. Dheda, S. Heysell, 2023, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.

A. Spanevello, R. Duarte, E. Martínez Robles, 2021, Pulmonology.

The appearance of sugI mixed loci in three individuals during treatment for MDR-TB, supports the involvement of sugI in Mycobacterium tuberculosis d-cycloserine resistance in vivo

F. van Leth, D. van Soolingen, M. Sturkenboom, 2023, bioRxiv.

Editorial: Pharmacology of infectious diseases: world tuberculosis day 2022

S. Wicha, S. Srivastava, J. Alffenaar, 2023, Frontiers in Pharmacology.

Multi-drug resistant tuberculosis in the Netherlands

J. Kosterink, J. Proost, O. Akkerman, 2016 .